Use of GLP-1 receptor agonists in patients with T2DM and chronic kidney disease Article (Web of Science)

cited authors

  • Aldrich, Sarah; Ashjian, Emily

publication date

  • March 1, 2019

webpage

published in

category

keywords

  • chronic kidney disease
  • diabetes
  • dialysis
  • dulaglutide
  • end-stage renal disease
  • exenatide
  • glucagon-like peptide-1 receptor agonist
  • liraglutide
  • lixisenatide
  • semaglutide
  • type 2 diabetes mellitus

start page

  • 20

end page

  • 28

volume

  • 44

issue

  • 3